Ubs Group Ag Assembly Biosciences, Inc. Transaction History

Ubs Group Ag

  • $397 Billion
  • Q1 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.65 - $1.25 $15,706 - $30,205
24,164 New
24,164 $19,000
Q1 2023

May 12, 2023
SELL
$0.8 - $1.74 $10,724 - $23,326
-13,406 Reduced 55.84%
10,601 $8,000
Q4 2022

Feb 08, 2023
BUY
$1.09 - $1.52 $13,707 - $19,115
12,576 Added 110.02%
24,007 $31,000
Q3 2022

Nov 10, 2022
BUY
$1.7 - $2.34 $18,395 - $25,321
10,821 Added 1773.93%
11,431 $19,000
Q2 2022

Aug 10, 2022
SELL
$1.35 - $2.29 $4,236 - $7,186
-3,138 Reduced 83.72%
610 $1,000
Q1 2022

May 16, 2022
SELL
$1.46 - $2.45 $3,758 - $6,306
-2,574 Reduced 40.71%
3,748 $8,000
Q4 2021

Feb 14, 2022
SELL
$2.13 - $3.46 $292,472 - $475,096
-137,311 Reduced 95.6%
6,322 $15,000
Q3 2021

Nov 15, 2021
BUY
$3.14 - $3.9 $4,666 - $5,795
1,486 Added 1.05%
143,633 $500,000
Q2 2021

Aug 13, 2021
BUY
$3.8 - $4.56 $480,947 - $577,136
126,565 Added 812.25%
142,147 $552,000
Q1 2021

May 12, 2021
BUY
$4.33 - $6.63 $34,938 - $53,497
8,069 Added 107.4%
15,582 $72,000
Q4 2020

Feb 11, 2021
BUY
$4.87 - $17.29 $12,725 - $45,178
2,613 Added 53.33%
7,513 $45,000
Q3 2020

Nov 12, 2020
SELL
$15.08 - $27.04 $23,404 - $41,966
-1,552 Reduced 24.05%
4,900 $81,000
Q2 2020

Jul 31, 2020
SELL
$14.57 - $23.96 $110,542 - $181,784
-7,587 Reduced 54.04%
6,452 $150,000
Q1 2020

May 01, 2020
SELL
$10.27 - $21.23 $124,688 - $257,753
-12,141 Reduced 46.38%
14,039 $208,000
Q4 2019

Feb 14, 2020
BUY
$8.36 - $23.81 $74,103 - $211,051
8,864 Added 51.19%
26,180 $536,000
Q3 2019

Nov 14, 2019
BUY
$9.83 - $14.82 $119,965 - $180,863
12,204 Added 238.73%
17,316 $170,000
Q2 2019

Aug 14, 2019
BUY
$12.9 - $20.8 $65,944 - $106,329
5,112 New
5,112 $69,000
Q1 2019

May 14, 2019
SELL
$17.7 - $24.93 $28,851 - $40,635
-1,630 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$19.05 - $36.45 $15,601 - $29,852
-819 Reduced 33.44%
1,630 $37,000
Q3 2018

Nov 14, 2018
BUY
$34.41 - $44.23 $80,622 - $103,630
2,343 Added 2210.38%
2,449 $91,000
Q2 2018

Aug 14, 2018
BUY
$39.21 - $50.29 $4,156 - $5,330
106 New
106 $4,000
Q1 2018

May 15, 2018
SELL
$41.7 - $64.16 $40,699 - $62,620
-976 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$28.58 - $49.91 $15,175 - $26,502
-531 Reduced 35.24%
976 $44,000
Q3 2017

Nov 14, 2017
BUY
$23.08 - $34.92 $13,894 - $21,021
602 Added 66.52%
1,507 $53,000
Q2 2017

Aug 14, 2017
SELL
N/A
-580 Reduced 39.06%
905 $19,000
Q1 2017

Nov 14, 2017
BUY
N/A
1,485
1,485 $38,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $665M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email